C000211329 Fees and Costs — VIP Health Care Portfolio, Service Class 2
Data updated: 2026-08-24
The net expense ratio is 0.84%: a 0.58% management fee, a 0.25% 12b-1 fee plus 0.01% other expenses. There are no sales loads or redemption fees. In fiscal 2025 the fund paid $330K in broker commissions, 0.0323% of average net assets, and portfolio turnover was 65%.
C000211329 Fees and Expenses
Annual operating expenses and sales charges of C000211329. Prospectus, as of April 30, 2026.
| Annual operating expenses | |
|---|---|
| Management fee | 0.58% |
| 12b-1 fee | 0.25% |
| Other expenses | 0.01% |
| Gross expense ratio | 0.84% |
| Fee waiver | — |
| Net expense ratio | 0.84% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
C000211329 Costs Over Time
On $10,000 invested in C000211329, assuming 5% a year before costs, total costs come to $547 over 5 years, cutting the return by 0.92% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.84%) | $88 | $276 | $479 |
| Trading costs (broker commissions) | $3 | $11 | $18 |
| Lost growth on money paid in costs | $0 | $14 | $50 |
| Total costs | $92 | $300 | $547 |
| Value after costs | $10,408 | $11,276 | $12,216 |
| Impact on return, per year | 0.92% | 0.92% | 0.92% |
C000211329 Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending December 31, 2025.
- Explicit cost rate (commissions ÷ average net assets): 0.0323%
- Total broker commissions: $330K
- Bought from dealers (principal trades, not a cost): $23.2M
- Portfolio turnover (prospectus): 65%
- Securities on loan, average value: $35.2M
- Net income from securities lending: $295K (0.029% of average net assets)
C000211329 Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| GOLDMAN SACHS GROUP INC (THE) | $39K | 16.17% |
| JEFFERIES FINANCIAL GROUP INC | $34K | 13.94% |
| MORGAN STANLEY | $32K | 13.25% |
| JPMORGAN CHASE and CO | $28K | 11.85% |
| BANK OF AMERICA CORPORATION | $27K | 11.06% |
| CITIGROUP INC | $25K | 10.27% |
| UBS GROUP AG | $16K | 6.74% |
| CONDOR TRADING LLC | $16K | 6.46% |
| THE TORONTO DOMINION BANK | $13K | 5.51% |
| TP ICAP GROUP PLC | $11K | 4.75% |
C000211329 Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| MORGAN STANLEY | $5.9M | 25.21% |
| JEFFERIES FINANCIAL GROUP INC | $5.1M | 21.89% |
| BANK OF AMERICA CORPORATION | $3.1M | 13.46% |
| JPMORGAN CHASE and CO | $3.1M | 13.32% |
| LEERINK PARTNERS LLC | $2.2M | 9.36% |
| THE TORONTO DOMINION BANK | $1.8M | 7.71% |
| GOLDMAN SACHS GROUP INC (THE) | $1.5M | 6.37% |
| GUGGENHEIM CAPITAL LLC | $623K | 2.68% |
VIP Health Care Portfolio Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| C000021062 | Initial Class | 0.59% | — |
| C000021063 | Investor Class | 0.67% | — |
| C000211329 | Service Class 2 | 0.84% | — |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.